Broadwood Partners L.P. buys STAAR Surgical shares at 42.56
| STAA Stock | USD 19.42 0.11 0.56% |
About 61% of STAAR Surgical's investor base is looking to short. The analysis of overall sentiment of trading STAAR Surgical stock suggests that many investors are alarmed at this time. The current market sentiment, together with STAAR Surgical's historical and current headlines, can help investors time the market. In addition, many technical investors use STAAR Surgical stock news signals to limit their universe of possible portfolio assets.
Broadwood Partners L.P. buys STAAR Surgical shares at 42.56
Read at investing.com
 |
STAAR Surgical Fundamental Analysis
We analyze STAAR Surgical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of STAAR Surgical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of STAAR Surgical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
STAAR Surgical is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
STAAR Surgical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with STAAR Surgical stock to make a market-neutral strategy. Peer analysis of STAAR Surgical could also be used in its relative valuation, which is a method of valuing STAAR Surgical by comparing valuation metrics with similar companies.
Peers
STAAR Surgical Related Equities
| NVST | Envista Holdings | 5.52 | ||||
| HOLX | Hologic | 1.01 | ||||
| RMD | ResMed | 0.80 | ||||
| HAE | Haemonetics | 0.26 | ||||
| ATR | AptarGroup | 0.03 | ||||
| MMSI | Merit Medical | 0.27 | ||||
| BDX | Becton Dickinson | 0.43 | ||||
| WST | West Pharmaceutical | 0.78 | ||||
| COO | Cooper Companies, | 0.78 | ||||
| MBOT | Microbot Medical | 1.56 | ||||
| ANGO | AngioDynamics | 1.83 | ||||
| ICUI | ICU Medical | 3.20 | ||||
| RGEN | Repligen | 3.61 |
Complementary Tools for STAAR Stock analysis
When running STAAR Surgical's price analysis, check to measure STAAR Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STAAR Surgical is operating at the current time. Most of STAAR Surgical's value examination focuses on studying past and present price action to predict the probability of STAAR Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STAAR Surgical's price. Additionally, you may evaluate how the addition of STAAR Surgical to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |